Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery
Unknown statusNot applicableNCT02838173
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study compare the "Serratus block plane" (SPB) and the local infiltration of the tissue in the prevention of acute and chronic pain after breast cancer surgery.
Study details
- Official title
- Serratus Plane Block for the Prevention of Chronic Pain After Breast Cancer Surgery
- Conditions
- Breast/Surgery
- Postoperative Complication
- Chronic Pain
- Interventions
- Procedure: serratus plane bloc : Ropivacaine 2mg/ml (0,3ml/kg)
- Procedure: tissue infiltration : Ropivacaine 2mg/ml (0,3ml/kg)
- Procedure: serratus plane bloc : placebo
- Procedure: tissue infiltration : placebo
- Sponsor
- Erasme University Hospital
- Start date
- 2016-07
- Primary completion
- 2017-12
- Sex
- Female
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Women scheduled for elective breast neoplasm surgery * Of ASA classification 1, 2 or 3 * Patients who provide written informed consent Exclusion Criteria: * Minor patients * Patients refusing to sign the consent * Patients included in another protocol within 3 months * Pregnant or lactating patients * Patients with history of allergy to local anesthetics (Ropivacaine) * Patients with contraindication to regional anesthesia (coagulopathy, local infection ...) * Patients with history of prior breast surgery (excluding diagnostic biopsy) * Patients with history of chronic pain * Patients with a history of psychiatric disorder
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02838173